The stock price of Sana Biotechnology Inc (NASDAQ: SANA) has surged by 1.23 when compared to previous closing price of 2.84, but the company has seen a 30.68% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-28 that SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in June. The presentations will feature a business overview and update.
Is It Worth Investing in Sana Biotechnology Inc (NASDAQ: SANA) Right Now?
The stock has a 36-month beta value of 1.80. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 3 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for SANA is 125.44M, and at present, short sellers hold a 32.95% of that float. On June 09, 2025, the average trading volume of SANA was 3.75M shares.
SANA’s Market Performance
SANA stock saw an increase of 30.68% in the past week, with a monthly gain of 58.84% and a quarterly increase of 14.09%. The volatility ratio for the week is 5.20%, and the volatility levels for the last 30 days are 7.50% for Sana Biotechnology Inc (SANA). The simple moving average for the last 20 days is 35.09% for SANA stock, with a simple moving average of -1.99% for the last 200 days.
Analysts’ Opinion of SANA
Many brokerage firms have already submitted their reports for SANA stocks, with Citizens JMP repeating the rating for SANA by listing it as a “Mkt Outperform.” The predicted price for SANA in the upcoming period, according to Citizens JMP is $5 based on the research report published on March 18, 2025 of the current year 2025.
Jefferies, on the other hand, stated in their research note that they expect to see SANA reach a price target of $7. The rating they have provided for SANA stocks is “Buy” according to the report published on March 14th, 2025.
SANA Trading at 54.53% from the 50-Day Moving Average
After a stumble in the market that brought SANA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.15% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at SANA starting from CHRISTIAN HORDO & KATHARINE HO, who proposed sale 75,000 shares at the price of $3.16 back on Feb 18 ’25. After this action, CHRISTIAN HORDO & KATHARINE HO now owns shares of Sana Biotechnology Inc, valued at $237,000 using the latest closing price.
CHRISTIAN HORDO & KATHARINE HO, the Officer of Sana Biotechnology Inc, proposed sale 75,000 shares at $3.86 during a trade that took place back on Jan 16 ’25, which means that CHRISTIAN HORDO & KATHARINE HO is holding shares at $289,500 based on the most recent closing price.
Stock Fundamentals for SANA
The total capital return value is set at -0.52. Equity return is now at value -71.44, with -37.04 for asset returns.
Based on Sana Biotechnology Inc (SANA), the company’s capital structure generated 0.3 points at debt to capital in total, while cash flow to debt ratio is standing at -2.26.
Currently, EBITDA for the company is -251.27 million with net debt to EBITDA at 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.40.
Conclusion
To sum up, Sana Biotechnology Inc (SANA) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
